Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients
Rafael Luque,
Zeid A. ALOthman,
Alina M. Balu,
Leonid Voskressensky
Affiliations
Rafael Luque
Departamento de Química Orgánica, Campus de Rabanales, Universidad de Córdoba, Edificio Marie Curie (C-3), Ctra Nnal IV-A, Km 396, 14014 Cordoba, Spain
Zeid A. ALOthman
Chemistry Department, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
Alina M. Balu
Departamento de Química Orgánica, Campus de Rabanales, Universidad de Córdoba, Edificio Marie Curie (C-3), Ctra Nnal IV-A, Km 396, 14014 Cordoba, Spain
Leonid Voskressensky
Department of Chemistry, Peoples Friendship University of Russia (RUDN University), 6 Miklukho Maklaya St., 117198 Moscow, Russia
A perspective on the use of heterogeneous catalysis to drive the waste-to-pharma concept is provided in this contribution based on the conversion of furanics to active pharmaceutical ingredients (APIs). The provided overview of the concept in this perspective article has been exemplified for two key molecule examples: Ancarolol and Furosemide.
